Fujirebio and Sysmex to supply the main raw materials of immunoassay reagents
The collaboration aims to utilize high-quality reagent materials, develop new parameters, and advance technologies in the future
14 Dec 2023
Fujirebio Holdings, Inc. and Sysmex Corporation have announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies.
In October 2023, Fujirebio and Sysmex entered into a basic agreement on business collaboration in the field of immunoassay, in a bid to promote cooperation to accelerate their global expansion, and to contribute to the development and advancement of immunoassay.
To promote specific initiatives, in November 2023, the two companies signed a Contract Development and Manufacturing Organization (CDMO) agreement related to dedicated reagents for the HISCL™ Series automated immunoassay system, involving the development of reagents for cerebral spinal fluid-based and blood-based testing in the field of neurodegenerative diseases, including Alzheimer's disease.
Under the terms of the Agreement, Fujirebio and Sysmex will supply a wide range of reagent materials owned by each company, mainly antigens and antibodies, which are the main raw materials of immunoassay reagents. This will enable the CDMO to accelerate reagent development, reduce costs, and maximize the value of raw material assets, as well as build a stable supply system for future global demand growth and prepare for raw material procurement risk in the event of an emergency.